NCT04819620View on ClinicalTrials.gov

Pharmacokinetics of PN-232 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

December 17, 2021

Study Completion Date

June 16, 2022

Conditions

Healthy Subjects

Interventions

DRUG

PN-232

Active Drug

DRUG

Placebo

Matching Placebo

Trial Locations (2)

5000

Protagonist Clinical Site, Adelaide

6009

Protagonist Study Site, Nedlands

All Listed Sponsors

lead

Protagonist Therapeutics, Inc.

INDUSTRY